The University of Warwick Library - WebBridge
NEAT-A: accelerated sequential epirubicin followed by higher dose 14 day CMF, using pegfilgrastim, is a feasible alternative for delivering dose dense E-CMF chemotherapy in early breast cancer
Bowden,
S..
14th European Cancer Conference (ECCO 14).
v.
Vol.5.
no.
No.4.
2007-09.
p.
194 -
195...
issn:
1359-6349
.
Sorry - based on the information provided, WebBridge cannot offer appropriate links.